<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: In patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, delays in controlling blood pressure are common, but the harms of delays have not been quantified </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To estimate the harms of delays in controlling systolic blood pressure in middle-aged adults with newly diagnosed Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Decision analysis using <z:mp ids='MP_0002055'>diabetes</z:mp> complication equations from the United Kingdom Prospective <z:mp ids='MP_0002055'>Diabetes</z:mp> Study (UKPDS) </plain></SENT>
<SENT sid="3" pm="."><plain>PARTICIPANTS: Hypothetical population of adults aged 50 to 59 years old with newly diagnosed Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> based on characteristics from the National Health and Nutrition Examination Surveys </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTION: Delays in lowering systolic blood pressure from 150 (uncontrolled) to 130 mmHg (controlled) </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN MEASURES: Lifetime complication rates (<z:mpath ids='MPATH_686'>amputation</z:mpath>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, and <z:hpo ids='HP_0001297'>stroke</z:hpo>), average life expectancy and quality-adjusted life expectancy (QALE) </plain></SENT>
<SENT sid="6" pm="."><plain>KEY RESULTS: Compared to a lifetime of controlled blood pressure, a lifetime of uncontrolled blood pressure increased complications by 1855 events per 10,000 patients and decreased QALE by 332 days </plain></SENT>
<SENT sid="7" pm="."><plain>A 1-year delay increased complications by 14 events per 10,000 patients and decreased QALE by 2 days </plain></SENT>
<SENT sid="8" pm="."><plain>A 10-year delay increased complications by 428 events per 10,000 patients and decreased QALE by 145 days </plain></SENT>
<SENT sid="9" pm="."><plain>Among complications, rates of <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> increased to the greatest extent due to delays </plain></SENT>
<SENT sid="10" pm="."><plain>With a 20-year delay in achieving controlled blood pressure, a baseline blood pressure of 160 mmHg decreased QALE by 477 days, whereas a baseline of 140 mmHg decreased QALE by 142 days </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Among middle-aged adults with <z:mp ids='MP_0002055'>diabetes</z:mp>, the harms of a 1-year delay in controlling blood pressure may be small; however, delays of ten years or more are expected to lower QALE to the same extent as smoking in patients with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>